Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 3Unknown 2Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 5Interventional 2

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1

Conditions

Hemangiosarcoma 1Carcinoma, Pancreatic Ductal 1

Interventions

Cisplatin 509Cyclophosphamide 360Carboplatin 352Radiotherapy 350Capecitabine 329Paclitaxel 325Oxaliplatin 324Gemcitabine 319Docetaxel 311Fluorouracil 283Drug Therapy 243apatinib 242Bevacizumab 229camrelizumab 214Etoposide 200Irinotecan 176Doxorubicin 175Leucovorin 161Dexamethasone 160sintilimab 142pembrolizumab 138anlotinib 136Pemetrexed 136Cytarabine 136toripalimab 129Neoadjuvant Therapy 122S 1 (combination) 120Vincristine 119Rituximab 117Radiosurgery 117

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Interventional × Urination × Clear all
NCT02817308 2018-08-31

Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas

Rambam Health Care Campus

Phase NA Unknown
100 enrolled
Gastrointestinal

Carcinoma, Pancreatic Ductal

NCT01786889 2016-07-29

ANGIHE

Centre Oscar Lambret

Phase NA Unknown
9 enrolled
Sarcoma

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡